Share your thoughts, experiences and ideas which could help others.
Please, no commercial content and no spam.
Make sure you enter your email address correctly so we can let you know when it goes live after a short moderation process.
Ranibizumab (trade name Lucentis) is a monoclonal antibody fragment (Fragment antigen-binding) derived from the same parent mouse antibody as bevacizumab (Avastin). It is much smaller than the parent molecule and has been Affinity maturation to pro...
Read more on Wikipedia